Latest Asx News

Wesfarmers outlines a bold growth and productivity agenda centred on AI integration, expanding retail footprints, and lithium project progress, underpinning strong shareholder returns and portfolio resilience.

Zenith Minerals urges shareholders to accept Forrestania Resources’ takeover offer valuing Zenith at a 78.6% premium to its 30-day VWAP, promising access to near-term production and a stronger combined gold portfolio.

Eden Innovations has wrapped up the second tranche of its $4 million institutional placement, issuing over 14 million shares at 18 cents each. The capital injection finalises the raise announced in April, with shares issued under ASX rules and ranking equally with existing stock.

Saferoads Holdings (ASX: SRH) has acquired Chameleon AMLS, adding a new modular trailer product line and appointing its founder Andrew Kaye to the board.

Tasman Resources has completed the first tranche of a $4 million share placement to fund a larger drilling program at its Parkinson Dam Project in South Australia.

Larvotto Resources has secured a binding seven-year gold concentrate offtake agreement with global giant Glencore for its Hillgrove project, complementing an existing antimony deal and paving the way for production in August 2026.

Diatreme Resources has finalised the sale of its Cape Flattery Silica Project to a joint venture with Sibelco, receiving $2.1 million in reimbursements and positioning for up to $7.4 million in total funding.

The Supreme Court of Western Australia has approved Genesis Minerals’ acquisition of Magnetic Resources, setting a clear timetable for scheme implementation and ASX trading suspension.

Novo Resources has delivered a maiden inferred resource estimate for the Leven Star Reef within its Belltopper Gold Project, outlining 87,000 ounces of contained gold and setting the stage for further exploration and resource expansion.

Macquarie Group Limited has fixed the Dividend Reinvestment Plan (DRP) price at AUD 233.12 per share for its final dividend payable on 2 July 2026, applying a 1.5% discount to the 10-day volume weighted average price. The final dividend is AUD 4.20 per share, fully franked at 35%.

Alice Queen Limited has pushed back the closing date for its partially underwritten rights issue to 19 June 2026, giving shareholders more time to subscribe at 0.9 cents per share.

Imugene’s off-the-shelf CAR T therapy azer-cel has won FDA Fast Track Designation for relapsed or refractory CLL/SLL and MZL, backed by compelling Phase 1b response rates.